Transdermal Buprenorphine: A Safer Option for Dyspnea and Rhinorrhea in End-Stage Pulmonary Disease

1. Describe the unique pharmacological properties of buprenorphine.2. Identify a novel treatment option for the symptomatic treatment of end-stage pulmonary diseases.

Source: Journal of Pain and Symptom Management - April 19, 2024 Category: Palliative Care Authors: Siji Thomas, Leanne K. Jackson Source Type: research